Compositions useful as inhibitors of JAK and other protein kinases
US7259161B2 · kind B2 · utility
48Cited by
0References
26Claims
0Family size
Assignee
Inventors
Key dates
| Filing date | Nov 4, 2003 |
| Grant date | Aug 21, 2007 |
| Priority date | — |
| Expiry date | Dec 20, 2023 |
Classification
- Technology area (CPC C)Chemistry; Metallurgy
- CPC primaryC07D413/14
- WIPO fieldPharmaceuticals
- WIPO sectorChemistry
Abstract
The present invention provides a compound of formula I:or a pharmaceutically acceptable salt thereof. The invention also provides pharmaceutically acceptable compositions comprising the compounds of the invention and methods of utilizing those compounds and compositions in the treatment of various protein kinase mediated disorders.
Source: USPTO / EPO open patent data. Objective bibliographic and citation counts.